Welcome to our dedicated page for WaveDancer news (Ticker: WAVD), a resource for investors and traders seeking the latest updates and insights on WaveDancer stock.
WaveDancer Inc. (WAVD) news centers on corporate and public-company disclosure matters, including material agreements, shareholder voting items, governance actions, capital-structure updates, risk factors, clinical or regulatory disclosures, and operating and financial results. Coverage also reflects the issuer's transition-related reporting context, with recurring attention to formal approvals, security-structure matters, and changes documented through company announcements and regulatory events.
WaveDancer (Nasdaq: WAVD) announced a 1-for-3 reverse stock split effective August 12, 2024, with trading on a split-adjusted basis starting August 13, 2024. The company will also change its name to Firefly Neuroscience, Inc. and trade under the symbol AIFF. This move will reduce outstanding shares from 2,013,180 to approximately 671,060. The split affects all stockholders uniformly, with fractional shares rounded up. Proportional adjustments will be made to equity awards, convertible preferred stock, and warrants. Post-merger, the total shares outstanding will be approximately 7,900,000.
Firefly Neuroscience, an AI-driven brain health company, has announced the appointment of Brian S. Posner to its board of directors following its planned merger with WaveDancer. The merger agreement has been approved by both companies' stockholders, and final closing conditions are being met. Posner brings 35 years of management experience, particularly in capital markets and corporate governance. He has previously served as CFO at multiple life science and technology firms, including electroCore and Cellectar Biosciences. CEO Jon Olsen believes Posner's expertise will significantly benefit Firefly's future growth.
Firefly Neuroscience, an AI-driven company specializing in mental health and neurological disorder solutions, has appointed David Johnson as Executive Chairman. This comes as the company finalizes its merger with WaveDancer (NASDAQ: WAVD). Johnson brings over three decades of healthcare and public company experience, having held leadership roles at Enveric Biosciences, Alliqua BioMedical, and ConvaTec. Firefly aims to leverage Johnson's expertise to drive growth and innovation. Both companies have received stockholder approval and are working towards meeting the final closing conditions of the merger agreement.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.